Navigation Links
Increased mortality rates seen in chronic hepatitis C patients with pre-cirrhotic advanced fibrosis
Date:4/7/2011

he authors noted that excess mortality occurred in the treatment group among patients with advanced fibrosis without cirrhosis.

"We followed the trial participants for an additional three years to investigate whether the increased mortality persisted and to explore causes of death," said lead study author Adrian Di Bisceglie, MD, FACP, Chairman of the Department of Internal Medicine at Saint Louis University School of Medicine in Missouri. For the current analysis, a committee of investigators reviewed deaths occurring during and after the HALT-C Trial to determine the cause of death. The committee categorized each death as liver- or non-liver related, and whether or not the death was associated with complications of peginterferon.

Analysis showed that 18% of the trial participants died (122) or underwent liver transplantation (74) over a median of 5.7 years. Two thirds of the deaths (62%) were attributed to end-stage liver disease or HCC and the remaining deaths (38%) were attributed to non-liver-related causes. The cumulative seven-year mortality rate was 20% for patients in the treatment group compared to 15% in the non-treatment control. Researchers observed differences in mortality rates (by seven years) between the treatment and non-treatment groups which were statistically significant for patients with fibrosis (14% and 7%, respectively) compared to those with cirrhosis (28% and 26%, respectively).

Researchers noted that the increase in mortality for patients treated with peginterferon did not emerge until three years into treatment and continued for several years after treatment ceased. The excess mortality in the treatment group was mainly linked to non-liver-related causes. "No specific cause of death accounted for the excess mortality, but deaths were unrelated to direct effects of peginterferon treatment," concluded Dr. Di Bisceglie. Researchers could not identify an excess frequency of any single condition or disease catego
'/>"/>

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Emergency department CT exams of children have increased substantially
2. Children of women who smoked during pregnancy at increased risk of becoming smokers
3. Traffic accidents linked to increased risk of chronic widespread pain
4. Gardening linked to increased vegetable consumption in older adults
5. Heavy drinking associated with increased risk of death from pancreatic cancer
6. Adults With HIV at Increased Risk of Bone Fractures, Study Finds
7. Acquisition of robotic technology leads to increased rates of prostate cancer surgery
8. Non-steroidal anti-inflammatory drugs linked to increased risk of erectile dysfunction
9. Multiple childbirth linked to increased risk of rare, aggressive triple-negative breast cancer
10. High Triglyceride Levels Linked to Increased Stroke Risk: Study
11. Cell-phone use not related to increased brain cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... length may be showing a genetic propensity for obesity as ... have been linked to increased body fat, but the same ... muscle, the researchers said. At 1 year, kids with ... and 3, however, these genes were linked to excessive weight ...
(Date:10/22/2014)... Maureen Salamon HealthDay ... A crucial part of conventional in vitro fertilization (IVF) -- ... instead take place in a device inside the vagina, new ... contend that the device, called an INVOcell, might sharply cut ... also make the technology more accessible to those who don,t ...
(Date:10/20/2014)... October 20, 2014 The newly updated ... source of thousands of facts, figures and forecasts on ... 68 medical sector forecast categories the Worldwide Medical ... regional and national views on the worldwide medical market ... The report gives you data for 2010-2019, covering each ...
(Date:10/20/2014)... 2014 ASCNYC (ascnyc.org) is a ... New Yorkers living with HIV/AIDS and other chronic ... recovery and self-sufficiency. Each year, ASCNYC spotlights selected ... through their tireless efforts. , Savills Studley ... has been selected as this year’s honoree for ...
(Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
Breaking Medicine News(10 mins):Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3
... Parker Named Interim Chief Financial Officer , , ... MDTH ), a healthcare provider focused on high ... cardiovascular disease, today announced that Art Parker, Senior Vice ... Financial Officer. Parker replaces Jeff Hinton, whose employment ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it will ... 10, 2009 at 4:30 pm Eastern Time. Dave Holveck, President and ... programs. , , The presentation will be webcast live and can ... the investors section. , , About Endo ...
... Scientists make strides in finding ways to slow tumor ... A protein called PHD2 that regulates blood vessel growth ... researchers who analyzed levels of the protein in tumor ... expression of PHD2, researchers at Stanford University School of ...
... CORAL GABLES, FL (June 5, 2009)--Dengue Fever (DF) and ... viral diseases in the World. Around 50-100 million cases ... of suffering this debilitating and sometimes fatal disease. Dengue ... an interdisciplinary team of researchers from the University of ...
... Interleukin Genetics, Inc. (NYSE Amex: ... President of Research and Development, will present findings that ... to weight-loss in overweight individuals at the American Diabetes ... Aziz will present the Company,s research at 8 a.m. ...
... --- Neighborhoods with restaurants, entertainment, cultural facilities and ethnic ... Chicago than neighborhoods where residents are less likely to ... facilities. , Published in the spring 2009 ... Immunology , the two-year study led by Ruchi Gupta, ...
Cached Medicine News:Health News:Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference 2Health News:Researchers develop the first climate-based model to predict Dengue fever outbreaks 2Health News:Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 2Health News:Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 3Health News:Asthma rates and where you live 2
(Date:10/22/2014)... -- AVACEN Medical announced today that its AVACEN 100 ... by the U.S. Food and Drug Administration. This clearance ... Internet for: the temporary relief of joint pain ... sprains . Logo - http://photos.prnewswire.com/prnh/20141021/153513 ... a sophisticated medical device incorporating over 3,000 firmware instructions ...
(Date:10/22/2014)... , Oct. 21, 2014   BioNano Genomics ... latest genomics research centers to purchase an ... the National Cancer Institute (NCI), NIH Intramural Sequencing ... Before Irys, obtaining a comprehensive view of a ... sequencing (NGS) does not deliver the scalability or ...
(Date:10/22/2014)... , Oct. 22, 2014 InVivo Therapeutics Holdings ... is revolutionizing spinal cord injury (SCI) treatment ... shown to outperform in tissue regrowth in the spinal ... Made from an FDA approved polymer, the scaffold ultimately ... harmless to the human body. NVIV has recently attracted ...
Breaking Medicine Technology:AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3
... ImmusanT, Inc. announced today it has raised ... Healthcare Partners LLC to advance development of the ... monitoring tool for celiac disease. The proceeds will ... to the point of demonstrating proof-of-concept. ImmusanT expects ...
... Dec. 13, 2011 IRIDEX Corporation (Nasdaq: IRIX ... for Health and Clinical Excellence (NICE) has issued a ... is not as cost effective as conventional laser photocoagulation ... treatment for diabetic macular edema (DME), a swelling of ...
Cached Medicine Technology:ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease 2ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease 3UK's National Health System Rejects Drug Therapy for Diabetic Macular Edema 2UK's National Health System Rejects Drug Therapy for Diabetic Macular Edema 3
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid Yeast Plus, a microbial identification system....
IDS Rapid NH, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
Medicine Products: